Medicinal Plants Classification Biosynthesis and ... - Index of

198
Jorge Castro-Garza, Delia E. Cruz-Vega and Ma. Teresa González-Garza
CDC. Fact sheet. Multidrug-Resistant Tuberculosis (MDR TB). 2008.
http://www.cdc.gov/tb/pubs/tbfactsheets/mdrt.tm
Chan, ED; Iseman, MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a
review. Current Opinion in Infectious Diseases, 2008, 21, 587-595.
Chen, JJ; Peng, CF; Huang, HY; Chen, IS. Benzopyrans, biphenyls and xanthones from the
root of Garcinia linii and their activity against Mycobacterium tuberculosis. Planta
Medica, 2006, 72, 473-477.
Chen, JJ; Wu, HM; Peng, CF; Chen, IS; Chu, SD. Seco-abietane diterpenoids, a
phenylethanoid derivative, and antitubercular constituents from Callicarpa pilosissima,
Journal of Natural Products, 2009, 72, 223–228.
Chou, TH; Chen, IS; Peng, CF; Sung, PJ; Chen, JJ. A new dihydroagarofuranoid
sesquiterpene and antituberculosis constituents from the root of Microtropis japonica.
Chem Biodivers, 2008, 5, 1412-1418.
Cruz-Vega, DE; Verde-Star, MJ; Salinas-González, N; Rosales-Hernández, B; Estrada-García,
I; Mendez-Aragón, P; Carranza-Rosales, P; González-Garza, MT; Castro-Garza J.
Antimycobacterial activity of Juglans regia, Juglans mollis, Carya illinoensis, and
Bocconia frutescens. Phytotherapy Research, 2008, 22, 557-559.
Dantas da Silva, LL; Nascimento, M; Siqueira Silva, DH; Furlan, M; da Silva Bolzani, V.
Antibacterial activity of a stearic acid derivative from Stemodia foliosa. Planta Medica,
2002, 68, 1137-1139.
Encarnación-Dimayuga, R; Agundez-Espinoza, J; García, A; Delgado, G; Molina-Salinas,
GM; Said-Fernández, S; Two new cassane-type diterpenes from Calliandra californica
with antituberculosis and cytotoxic activities. Planta Medica, 2006, 72, 757-61.
Espinal, MA; Salfinger, M. Global impact of multidrug resistance. In Cole, ST; Eisenach;
KD; McMurray, DN; Jacobs Jr, WR. Tuberculosis and the tubercule bacillus. Washington
DC: ASM Press, 2005, 101-114.
Gautam, R; Saklani, A; Sanjay, M; Jachak, SM. Indian medicinal plants as a source of
antimycobacterial agents. Journal of Ethnopharmacology, 2007, 110, 200–234.
Garzón, MC; Angée, DY; Llerena, C; Orjela, DL; Victoria, JE. Surveillance of
Mycobacterium tuberculosis resistance to antituberculosis drugs. Biomedica, 2008, 28,
319-326.
Gibbons, S; Fallah, F; Wright, CW. Cryptolepine hydrochloride: a potent antimycobacterial
alkaloid derived from Cryptolepis sanguinolenta. Phytotherapy Research, 2003, 17,
434-436.
Graham, JG; Pendland, SL; Prause, JL; Dansinger, LH. Antimycobacterial evaluation of
Peruvian plants. Phytomedicine, 2003, 10, 528-535,
Gu, JQ; Wang, Y, Franzblau, SG, Montenegro, G; Yang, D; Timmermann BN. Antitubercular
constituents of Valeriana laxiflora. Planta Medica, 2004, 70, 509-514.
Gutierrez-Lugo, MT; Bewley, CA. Natural products, small molecules, and genetics in
tuberculosis drug development. Journal of Medical Chemistry, 2008, 51, 2606–2612.
Hesseling, AC; Cotton, MF; Jennings, T; Whitelaw, A; Johnson, LF; Eley, B; Roux, P;
Godfrey-Faussett, P; Schaaf, HS. High incidence of tuberculosis among HIV-infected
infants: evidence from a South African population-based study highlights the need for
improved tuberculosis control strategies. Clinical Infectious Diseases, 2009, 48, 108-114.